STERIS announces the addition of disinfection and virucidal activity claims in the United States for CIP 200™ Acid-Based Cleaner and Disinfectant. The new label claims are the result of extensive testing and development.
CIP 200™ Acid-Based Cleaner and Disinfectant has received the following biocidal claims on washable, hard, nonporous surfaces in the presence of 5% organic soil (serum) when used at a 1% concentration of product:
- Staphylococcus aureus (ATCC 6538) in 10 minutes at or above 60 °C.
- Pseudomonas aeruginosa (ATCC 15442) in 10 minutes at or above 60 °C.
Additionally, CIP 200 Acid-Based Cleaner and Disinfectant is effective against Bovine Viral Diarrhea Virus (BVDV) when used at a 1% concentration of product per gallon of deionized water in 5% blood serum at 60°C for a contact time of 10 minutes.
CIP 200™ Acid-Based Cleaner and Disinfectant is available in the United States beginning in January 2021. CIP 200™ Acid-Based Process and Research Cleaner will continue to be available globally. For US-based Customer’s currently using CIP 200™ Acid-Based Process and Research Cleaner, the transition to CIP 200™Acid-Based Cleaner and Disinfectant does not impact the formulation of the product and will not require requalification or revalidation.
STERIS continues to meet our Customers’ validation objectives and quality needs with innovative product claims, an extensive documentation package, and support from the STERIS Technical Services team. For more information about this and other STERIS formulated chemistry products, please visit www.sterislifesciences.com
At STERIS, OUR MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe. For more information, visit www.steris.com.